Industry News
Stay up-to-speed with our monthly round-up of the latest developments from across the industry.
If you would like to receive updates via our newsletter then please sign up here.
Haemostasis Q2 2025 News
Our round-up of the latest developments from across the haemostasis industry for Q2 2025, including the latest data presentations at ISTH 2025. REGULATORY FDA approved Bayer’s Jivi (a recombinant extended half-life factor VIII concentrate) for use in paediatric patients 7 years of age and older with haemophilia A based on Alfa-PROTECT and PROTECT Kids trial […]
Infectious Diseases News – Spring 2025
Our round-up of the latest developments from across infectious disease research and prevention in Spring 2025. DIAGNOSTICS The WHO published its first analysis of commercially available and pipeline diagnostic products for invasive fungal diseases caused by WHO Fungal Priority Pathogens and the identifiable gaps.(19 Mar) The WHO issued the information notice for users of malaria […]
Haemostasis March 2025 News
Our round-up of the latest developments from across the haemostasis industry for March 2025. REGULATORY Genentech’s TNKase (tenecteplase, tissue plasminogen activator) was approved by the FDA for the treatment of acute ischemic stroke (AIS) in adults, administered as a single 5-second intravenous (IV) bolus (3 Mar) Sanofi / Alnylam’s Qfitlia (fitusiran, antithrombin RNAi) was approved by […]
